AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease
With both new and revised measures, the document’s authors aim to provide clinicians usable advice in a digestible format.
Related Articles
How much ultra-processed food is too much? The exact amount that raises your risk of heart disease and cancer
Each additional 3.5 ounces a day of ultra-processed food consumption was associated with a higher risk of a range of health issues.
Evolocumab May Shift Plaque Profile Toward Lower Cardiovascular Risk
Evolocumab reshapes arterial plaque, reducing cardiovascular risk by lowering microcalcification and shifting plaque composition over 18 months.
How the ‘Canceling’ of DEI Impacts Cardiology
Leslie Cho and Robert Roswell explain how the rollback of diversity, equity, and inclusion initiatives will impact clinical research, patient care, and health equity.
Evolocumab May Shift Plaque Profile Toward Lower Cardiovascular Risk
Evolocumab reshapes arterial plaque, reducing cardiovascular risk by lowering microcalcification and shifting plaque composition over 18 months.
Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study
The findings underscore the need to treat heart failure with urgency and double down on clinician education, one expert says.
When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer
Approximately one in four patients died, deteriorated to a higher shock stage, or were transferred for a higher level of care.
When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer
Approximately one in four patients died, deteriorated to a higher shock stage, or were transferred for a higher level of care.
FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis
The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.
New Study Traces Sharp Regional Shifts in Ischemic Heart Disease Burden — A Global Warning Signal – American College of Cardiology
Contact: Ju lie Boyland, jboyland@acc.org , A new study puts the spotlight on the rising burden of ischemic heart disease across Southeast Asia, East Asia…
Lp(a) Genetics Differ Between Populations but Have Similar Clinical Impact
The main message is that absolute levels of Lp(a) matter more than which genes may have caused them, Robert Clarke says.
